Submit Deal

PHARMATHEN

HQ - Marousi

Summary

Pharmathen is a company specializing in innovative life cycle management solutions for branded pharma, focusing on developing and establishing new technology platforms to enhance drug delivery through innovative techniques and advanced technologies.

Deals Overview

Total Deals4

Valued Deals1

Total Value£ 1.37 B

Avg. Deal Size£ 1.37 B

Market Context

Senior Management

John Nason
Group CEO
Dimitris Kadis
CEO
Diomedes Vassiliou
CFO

Sort

latham & watkins

HQ - New York, United States

legal advisors (2)

2 Shared Deals

2 Along

£ 1.37 B

Total Value

ropes & gray

HQ - Boston

legal advisors (2)

2 Shared Deals

1 For | 1 Opposite

£ 1.37 B

Total Value

clifford chance

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 1.37 B

Total Value

ernst & young

HQ - London, United Kingdom

accounting advisors (1)

1 Shared Deal

1 Opposite

£ 1.37 B

Total Value

nautadutilh

HQ - Amsterdam, Netherlands

legal advisors (1)

1 Shared Deal

1 Opposite

£ 1.37 B

Total Value

bernitsas

HQ - Athens, Greece

legal advisors (1)

1 Shared Deal

1 Opposite

£ 1.37 B

Total Value

jefferies & company

HQ - New York, United States

financial advisors (1)

1 Shared Deal

1 Along

£ 1.37 B

Total Value

kirkland & ellis

HQ - Chicago, United States

legal advisors (1)

1 Shared Deal

1 Along

£ 1.37 B

Total Value

prosek partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 Along

£ 1.37 B

Total Value

de brauw blackstone westbroek

HQ - Amsterdam

legal advisors (1)

1 Shared Deal

1 Along

£ 1.37 B

Total Value

pricewaterhousecoopers

HQ - London

accounting advisors (1)

1 Shared Deal

1 Along

£ 1.37 B

Total Value

morrison foerster

HQ - San Francisco

legal advisors (1)

1 Shared Deal

1 Along

£ 1.37 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy